Dabigatran-etexilate/rivaroxabanMid-gastrointestinal bleeding.: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1908卷 / 1期

关键词：

D O I：

10.1007/s40278-022-15922-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：194 / 194

相关论文

共 50 条

[1] Dabigatran-etexilate/warfarinHaematuria and gastrointestinal bleeding: 2 case reports
Reactions Weekly, 2021, 1863 (1) : 117 - 117
[2] Dabigatran-etexilate overdoseUpper gastrointestinal bleeding and haemorrhagic shock: 2 case reports
Reactions Weekly, 2018, 1730 (1) : 111 - 111
[3] Dabigatran-etexilate/streptokinaseUpper gastrointestinal bleeding: case report
Reactions Weekly, 2020, 1808 (1) : 101 - 101
[4] Apixaban/dabigatran-etexilate/rivaroxabanExcessive bleeding : 3 case reports
Reactions Weekly, 2022, 1920 (1) : 80 - 80
[5] Aspirin/dabigatran-etexilate/warfarinLack of efficacy and gastrointestinal bleed: 2 case reports
Reactions Weekly, 2023, 1938 (1) : 245 - 245
[6] Dabigatran-etexilate/heparinThrombocytopenia and oozing: 2 case reports
Reactions Weekly, 2021, 1854 (1) : 123 - 123
[7] Aspirin/dabigatran-etexilate/rivaroxabanBleeding: 2 case reports
Reactions Weekly, 2022, 1898 (1) : 75 - 75
[8] Apixaban/dabigatran-etexilate/rivaroxabanMajor and minor bleeding: 3 case reports
Reactions Weekly, 2021, 1883 (1) : 59 - 59
[9] Dabigatran etexilate/rivaroxabanUterine major bleeding and gastrointestinal bleeding: 2 case reports
Reactions Weekly, 2018, 1695 (1) : 134 - 134
[10] Dabigatran-etexilate/heparin/warfarinPost-polypectomy bleeding: 8 case reports
Reactions Weekly, 2019, 1743 (1) : 74 - 74

← 1 2 3 4 5 →